MENU
LYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.28M
P/E Ratio
N/A
Total Cash
51.63M
Projected Growth
N/A
Total Debt
35.32M
Revenue
1.47M
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash/Share
0.79
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
LYRA
Capitalization
11.3M
P/E Ratio
N/A
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash
51.6M
Total Cash/Share
0.79
Total Debt
35.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
1.47M
ROE
N/A
Book Value
20.6M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-1.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
65K
Current Ratio
3.64
Current Revenue Per Employee
2241.38
Dividends Per Share - Security
N/A
EBITDA
-67.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-97.94
Shares Held By Institutions
9.74M
Shares Outstanding - Current
65.5M
Total Liabilities
58.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-96.712
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com